University of Chicago First to Offer Newly Approved Drug for Multiple Sclerosis
University of Chicago Medical CenterThe first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.